StigmaScope
Explore Stigma in the US
  • View Map
  • About the Project
  • Methodology
Jump to state:
Select a State
  • Alabama
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • District of Columbia
  • Florida
  • Georgia
  • Hawaii
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • Tennessee
  • Texas
  • Utah
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin

Methodology

What is the StigmaScope dashboard?

Visualizing and measuring stigma is essential to Ending the HIV Epidemic in the United States and around the world, as stigma experienced in both social and healthcare-related settings can deter individuals from seeking and staying engaged in HIV prevention and treatment services. Without quantifying these experiences, critical barriers to HIV service engagement will remain unmeasured and without response. Through the visualization of the experience and impacts of stigma, this dashboard aims to bridge gaps facilitating the implementation and evaluation of evidence-based stigma mitigation strategies in HIV treatment and prevention.

StigmaScope has been developed in response to stakeholder feedback including health departments, community-based organizations, and affected communities. Phase 1 included the development of the Data Incubator: Stigma, which served as a visualization of stigma-related data among gay, bisexual, and other men who have sex with men in three states: Georgia, New York, and Maryland. Phase 2, the focus of the current site, includes the visualization of experiences of stigma and the HIV care cascade in two different modules on the StigmaScope site. Module 1 – Explore, visualizes key stigma metrics and factors that contribute to multiple forms of stigma affected communities. Module 2 – Analyze, visualizes key HIV service indicators, stigma, and related variables such as social support, and knowledge of care. Phase 3 of StigmaScope will include the development of an interactive systems dynamics model that visualizes the relationship between stigma and HIV service indicators. With Phase 3 of StigmaScope, users will be able to simulate the effects of different levels of stigma including the potential effect of stigma mitigation interventions on HIV service indicators.

Module 1 – Explore

AMIS for Stigma Aggregation: Responses of “yes,” regardless of time frame, are coded as positive evidence of experiencing stigma. Missing responses are imputed using the mean within the three defined stigma domains. Scores are aggregated to calculate state-level proportions.

Note: States failing to meet a minimum threshold of 30 respondents for a specific item in a given survey year are suppressed and shaded grey. 

General Social Stigma

Experiences of negative treatment or violence from police or others, including physical and sexual violence.5

Anticipated Healthcare Stigma

Fear of, or negative experiences in, healthcare services that may lead to avoidance of care.5

Stigma from Family and Friends

Experiences of exclusion, discrimination, or rejection from friends and/or family.5

MAP for Structural Stigma: Collated from MAP’s HIV Criminalization and Hate Crime legislation pages, this policy data displays active HIV criminalization laws, hate crime data collection, and annual hate crime incidence.

Module 2 – Analyze

AMIS for Sociobehavioral Trends:

Visualizes the proportion of participants responding “yes” to individual socio-behavioral variables, including the three core stigma constructs, healthcare provider disclosure, and risk behavior. For stigma constructs, to more finely characterize temporal trends, responses of ‘yes’ are coded as positive evidence of stigma experience only if experienced within the last 6 months. To facilitate accurate trend visualization and cross-state comparisons, this data is grouped into two-year intervals and reweighted across time.

CDC for HIV-related Indicators:
Tracks key epidemiological and service indicators among MSM, specifically:

MSM prescribed Pre-Exposure Prophylaxis (PrEP)
Derived from the CDC surveillance indicator “PrEP coverage and number of persons prescribed.” The number of MSM prescribed PrEP is estimated as 85% of male PrEP users, based on national estimates.

Estimated HIV incidence among MSM
Derived from the CDC surveillance indicator ‘Estimated HIV incidence’ only for all transmission categories. MSM incidence is estimated by allocating total incidence based on the proportion of new HIV diagnoses attributed to MSM (excluding AIDS classifications).
Note: This approach assumes that the share of new diagnoses among MSM reflects the share of new infections.

HIV diagnoses among MSM
Taken directly from CDC surveillance indicator: ‘HIV diagnoses’

Data Sources

American Men’s Internet Survey (AMIS)

Source Description: a cross-sectional, annual online survey occurring annually since 2013, led by Emory University in partnership with Johns Hopkins University. AMIS aims to capture the demographics, sexual behavior, HIV and STI testing and diagnosis history, PrEP knowledge, interest, and use, use of HIV prevention services, and experiences of stigma of gay, bisexual, and other men who have sex with men (GBMSM) in the United States.

  • Module 1 – Data Visualizations:
    • National Heatmap: The proportion of AMIS participants who have experienced stigma from family and friends, and in general and social settings in each state.
      • States shaded grey did not meet the threshold of at least 30 respondents to the item in a survey year, from 2017 – 2022
      • State-level stigma scores represent the proportion of AMIS participants reporting experiences of stigma across 1) family and friends’ stigma, 2) anticipated stigma in healthcare, and 3) general social stigma. For stigma-related questions in AMIS, responses of “yes, in the last 6 months” or “yes, but not in the last 6 months” are coded as evidence of experiencing stigma. Missing responses are imputed using the mean within each of the three stigma domains. Scores are then aggregated at the state level to show the percentage of participants reporting stigma.
    • State Profile Pages: The proportion of AMIS participants who responded yes to individual items which make up the overall stigma scales, (e.g. experiencing stigma from family and friends, and in general and social setting) are displayed.
  • Module 2 – Data Visualizations:
    • Show the proportion of participants reporting “yes” to individual socio-behavioral variables, including various forms of stigma, knowledge of care navigation, degree of outness, and risk behaviors.
      • Proportions are standardized across time to allow for trend visualization and comparison across states

Movement Advancement Project (MAP)

Source Description: Collated data from MAP’s HIV Criminalization and Hate Crime legislation pages

  • Data Visualization:
    • State Profile Pages: shows whether the state has HIV Criminalization laws and if the state requires hate crime data to be collected, along with hate crimes committed per year since 2021

Centers for Disease Control and Prevention (CDC) HIV Surveillance Reports

Source Description: Data compiled annually from multiple national reporting systems, including:

    • National HIV Surveillance System – case-based surveillance
    • IQVIA Real World Data–Longitudinal Prescriptions database – prescription data repositories
    • Medical Monitoring Project – national surveys
  • Data Visualization:
    • HIV Service Indicator Graphs: Present trends over time for key HIV prevention and care indicators among MSM, derived from CDC surveillance data. These include HIV testing, linkage to care, retention in care, ART use, and viral suppression.
      • Where MSM-specific values are not directly reported by CDC, derived estimates are used based on clearly defined formulas detailed in the accompanying variable table (under Data Definitions)

Data definitions

The table below shows the specific data variables, their definitions, and sources. Given that the next phase of the dashboard will incorporate these data variables as part of the system dynamics model, the data is categorized by the type of variable it is defined as in the model.

Variable Name Variable Type Unit Initial Parameter Values and Formulas Variable Definition/Specification Sources of Initial Parameters and Variable Values
On PrEP Stock Persons (% MSM among males prescribed PrEP) × (Number of males prescribed PrEP) Represents MSM currently prescribed PrEP each year.

% MSM on PrEP is assumed to be 85% of male PrEP users.

CDC surveillance data (IQVIA Real World Data); external epidemiological estimates.
Off PrEP Stock Persons (% MSM among males not prescribed PrEP) × (At Risk MSM Population) Represents MSM not on PrEP in a given year.

% MSM not on PrEP is calculated as (1 – % MSM on PrEP).

CDC surveillance data (IQVIA Real World Data).
Receipt of HIV medical care not yet virally suppressed Stock Persons (Receipt of HIV medical care (MSM)) – (Virally suppressed (MSM)) PLWH who have had at least one CD4 or viral load test in the past year but are not virally suppressed (<200 copies/mL). CDC surveillance indicators for HIV medical care and viral suppression (MSM).
Lost to HIV care Stock Persons (Knowledge of Care) × (% MSM receiving HIV medical care) – (Receipt of HIV medical care (MSM)) PLWH who know their status but did not take at least one CD4 or viral load test in the past year. CDC HIV surveillance data (knowledge of status and receipt of HIV medical care).
Virally suppressed Stock Persons Virally suppressed (MSM) PLWH who have viral load <200 copies/mL in the past year, indicating suppression. CDC ‘HIV viral suppression’ indicator for MSM.
Undiagnosed Stock Persons (Estimated prevalence) × (% MSM receiving HIV medical care) – (Knowledge of Care) × (% MSM receiving HIV medical care) PLWH who have not yet been diagnosed. CDC surveillance data (estimated prevalence and knowledge of status indicators).
New diagnoses (not AIDS) Flow Persons/year HIV diagnoses – AIDS classifications Annual new HIV diagnoses without AIDS at testing. CDC surveillance data indicators for HIV diagnoses and AIDS classifications.
New diagnoses (AIDS) Flow Persons/year AIDS classifications Annual new HIV diagnoses with simultaneous AIDS classification. CDC ‘AIDS classifications’ indicator.
Incidence Flow Persons/year Estimated incidence Annual rate of new HIV infections (estimated). CDC HIV surveillance data (estimated incidence).

 

References

  1. American Men’s Internet Survey (AMIS). Retrieved March 2026, from https://emoryamis.org/
  2. Movement Advancement Project. Hate Crime Laws. Retrieved September 16, 2025, from https://www.lgbtmap.org/home
  3. Movement Advancement Project. HIV Criminalization Laws. Retrieved September 16, 2025, from https://www.lgbtmap.org/equality-maps/hiv_criminalization_laws
  4. Centers for Disease Control and Prevention. NCHHSTP AtlasPlus. Retrieved March 2026, from https://www.cdc.gov/nchhstp/about/atlasplus.html
  5. Augustinavicius, J. L., et al. (2020). Characterizing Cross-Culturally Relevant Metrics of Stigma Among Men Who Have Sex With Men Across 8 Sub-Saharan African Countries and the United States. American Journal of Epidemiology, 189(7), 690–697. https://doi.org/10.1093/aje/kwz270

 

Get in Touch For more information and updates, please share your name and email below.